Company Search:
Advanced Search
Sponsored Links
Lonza Group AG Company Snapshot
Lonza Group AG operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lonza Group AG with three other pharmaceutical manufacturers in Europe: H. Lundbeck A/S of Denmark (2016 sales of 15.63 billion Danish Kroner [US$2.26 billion] of which 19% was Other Pharmaceuticals), UCB Sa of Belgium (4.18 billion Euro [US$4.49 billion] of which 100% was Biopharmacy), and Ipsen SA which is based in France (1.67 billion Euro [US$1.79 billion] ).

Sales Analysis. During the year ended December of 2016, sales at Lonza Group AG were 4.13 billion Swiss Francs (US$4.14 billion). This is an increase of 8.7% versus 2015, when the company's sales were 3.80 billion Swiss Francs. This was the third consecutive year of growth at Lonza Group AG.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lonza Group AG
  Stock Performance Chart for Lonza Group AG
  Stock Data: Recent Stock Performance:
  Current Price (3/17/2017): 184.80
(Figures in Swiss Francs)
1 Week 0.2%   13 Weeks 2.9%  
4 Weeks 9.0%   52 Weeks 15.9%  
Lonza Group AG Key Data:
  Ticker: LONN Country: Switzerland
  Exchanges: FRA GVA OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 4,132,000,000
(Year Ending Jan 2017).
Employees: 9,829
  Currency: Swiss Francs Market Cap: 9,661,830,948
  Fiscal Yr Ends: December Shares Outstanding: 52,282,635
  Share Type: Namenaktie Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.